Brookline Capital Management Weighs in on Adial Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:ADIL) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) and Adial Pharmaceuticals (NASDAQ:ADIL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. Analyst Recommendations This is a summary of […]
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Free Report) – Stock analysts at Brookline Capital Management decreased their FY2023 earnings per share (EPS) estimates for Adial Pharmaceuticals in a research note issued on Tuesday, November 14th. Brookline Capital Management analyst K. Dolliver now expects that the company will earn ($5.46) per share for the year, down from […]
Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company's Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug Dependence streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.